Vlad Vasile-Voiculescu· Renew

Unverifiable

80% of basic medicines used in Europe depend on raw materials and production from outside the European Union.

Omissions

• The claim lacks specificity on what constitutes 'basic medicines' (generic drugs, essential medicines, antibiotics, etc.)
• No distinction is made between dependency on raw materials versus dependency on finished production
• The claim does not specify the source or methodology for the 80% figure
• Available pharmaceutical trade data (EFPIA) shows significantly lower import dependency for total pharmaceutical consumption (24.7% from outside Europe)

Sources

• PrimaryEuropean Federation of Pharmaceutical Industries and Associations (EFPIA) - Production, Import Dependencies and Export Vulnerabilities of Pharmaceuticals for the EU2724.7% of EU27 pharmaceutical consumption is imported from outside Europe, mainly the US; 17.5% imported from other European countries
• PrimaryEuropean Parliament - Potential measures to facilitate the production of active pharmaceutical ingredients in the EUPharmaceutical production including medicines as finished products, raw materials and active pharmaceutical ingredients (APIs) left Europe over past decades
• PrimaryEurostat - International trade in medicinal and pharmaceutical productsIn 2024, EU had trade surplus of €194 billion in medicinal/pharmaceutical products